Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Bioceres Crop Solutions (BIOX) Other Operating Expenses (2017 - 2025)

Historic Other Operating Expenses for Bioceres Crop Solutions (BIOX) over the last 9 years, with Q3 2025 value amounting to -$195676.0.

  • Bioceres Crop Solutions' Other Operating Expenses rose 6265.89% to -$195676.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $6.9 million, marking a year-over-year increase of 93134.02%. This contributed to the annual value of $6.8 million for FY2025, which is 55216.69% up from last year.
  • Bioceres Crop Solutions' Other Operating Expenses amounted to -$195676.0 in Q3 2025, which was up 6265.89% from -$1.5 million recorded in Q2 2025.
  • Bioceres Crop Solutions' Other Operating Expenses' 5-year high stood at $8.1 million during Q1 2025, with a 5-year trough of -$1.5 million in Q2 2025.
  • Its 5-year average for Other Operating Expenses is $122047.4, with a median of -$195676.0 in 2025.
  • As far as peak fluctuations go, Bioceres Crop Solutions' Other Operating Expenses crashed by 2219281.31% in 2021, and later skyrocketed by 497084.36% in 2025.
  • Quarter analysis of 5 years shows Bioceres Crop Solutions' Other Operating Expenses stood at -$571365.0 in 2021, then soared by 150.84% to $290487.0 in 2022, then plummeted by 501.6% to -$1.2 million in 2023, then surged by 147.13% to $549863.0 in 2024, then crashed by 135.59% to -$195676.0 in 2025.
  • Its Other Operating Expenses was -$195676.0 in Q3 2025, compared to -$1.5 million in Q2 2025 and $8.1 million in Q1 2025.